Abstract and Introduction Clinical Features of Tuberous Sclerosis Complex Genetics of Tuberous Sclerosis Diagnosis of Tuberous Sclerosis Complex by DNA Analysis References Hypomelanotic macules (ash ...

Please provide your email address to receive an email when new articles are posted on . Survey responses reflected positive language and communication outcomes after cannabidiol use. Further ...

Patients with tuberous sclerosis complex, a genetic disorder characterized by the growth of noncancerous tumors in multiple organs of the body, have limited treatment options. A team led by ...

A team of researchers led by UCL Great Ormond Street Institute of Child Health (ICH) and Great Ormond Street Hospital (GOSH) has found that metformin - a drug commonly used to treat Type 2 diabetes - ...

The Company plans to discontinue further clinical development of ganaxolone in TSC. Marinus Pharmaceuticals announced that its phase 3 trial of ganaxolone did not meet the primary end point for the ...

Tuberous sclerosis complex (TSC) is a rare genetic condition that causes non-cancerous (benign) tumors in various organs of the body, including in the brain. It is also accompanied by patches of ...

・A mouse model of tuberous sclerosis complex (TSC) had abnormal dendritic spine morphology and neuronal dysfunction. These abnormalities were rescued by the administration of a Rheb inhibitor. ・This ...

VENICE, LOS ANGELES (KABC) -- A Venice family hopes to raise money and awareness to fight an incurable neurological disease that affects children. Tuberous sclerosis complex changed their lives ...

California, USA-based clinical-stage biopharmaceutical company Aeovian Pharmaceuticals revealed it has closed an oversubscribed $55 million Series B financing that will fund completion of a Phase II ...

Tuberous sclerosis complex is a dominantly inherited disorder affecting multiple organs; because of its phenotypic variability, the diagnosis of tuberous sclerosis complex can be difficult in the ...